ANXA2 and prostate cancer: Another report demonstrated that thereduction in cell surface ANXA2 expression in response to changes in interferongamma levels leads to reduced prostate cancer cell invasion[28], suggesting that the cellsurface translocation of ANXA2 may be an important cellular process for multipletypes of cancers[10].